
XERIANT, INC.
93
Recent news coverage does not directly report on Xeriant's business developments but reflects broader market conditions relevant to sectors in which the company operates.
- Rising Indian sugar production has weighed on prices, indicating commodity market pressures [N1].
- Sugar prices have slid as India increases sugar production, reflecting supply dynamics [N2].
- CapsoVision narrowed its Q3 loss and plans FDA clearance application, illustrating sector activity [N3].
- Walmart appointed Joseph E. Creed to its Board of Directors, signaling corporate governance updates in the retail sector [N4].
- Ballard Power Systems acquired GeoPura Limited and reported Q3 2026 results, showing M&A activity in clean energy [N5].
- Galectin Therapeutics reported September 30, 2026 financial results and a significant debt conversion, highlighting financial restructuring in biotech [N6].
- Stocks settled lower on rising bond yields, indicating macroeconomic pressures [N7].
- Natural gas prices fell following the lifting of force majeure on the Appalachian pipeline, affecting energy markets [N8].
Xeriant, Inc. is dedicated to the discovery, development, and commercialization of transformative technologies with a focus on advanced materials applicable across multiple industrial sectors. Its flagship products under the DUREVER™ brand include NexBoard™, an eco-friendly composite construction panel made from recycled materials, and NexPatch™, a fire-resistant joint compound. Both products utilize the proprietary Durazite™ fire-retardant technology. NexBoard™ is designed to replace conventional construction materials and has demonstrated strong resistance to fire, water, mold, insects, and physical damage. The company pursues strategic partnerships to leverage existing distribution networks and reduce capital requirements. Xeriant also operates Factor X Research Group, an innovation engine targeting aerospace, defense, AI, quantum computing, and other advanced technology domains. The company has experienced financial restructuring related to bridge loans and convertible notes, with ongoing efforts to secure funding and scale production through contract manufacturing and potential green bond financing.
Xeriant, Inc. is a technology company specializing in advanced materials marketed under the DUREVER™ brand, including NexBoard™ and NexPatch™, which incorporate proprietary fire-retardant technology Durazite™. The company focuses on eco-friendly composite construction materials designed to replace traditional building products. Xeriant has developed Factor X Research Group to drive innovation across multiple high-tech domains. The company has undergone significant financial restructuring, including a settlement agreement with Auctus Fund LLC to manage debt obligations. As of September 30, 2026, Xeriant reported a net loss and low liquidity ratios, reflecting ongoing financial challenges. The company is actively scaling production through contract manufacturers and pursuing strategic partnerships and financing options. Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice [S1][S2].
Xeriant's advanced materials, particularly NexBoard™ with its proprietary Durazite™ technology, offer a potentially universal replacement for multiple construction materials, supported by extensive third-party certification testing. The company's strategic approach to partnerships and licensing could enable rapid market access with reduced capital risk. Factor X Research Group's broad technology focus may identify additional breakthrough opportunities across aerospace, defense, AI, and quantum computing sectors, enhancing long-term value creation. Successful scaling of production and execution of licensing agreements could generate meaningful near-term revenue streams.
Xeriant faces significant financial challenges, including low liquidity ratios and net losses, which may constrain its ability to scale production and fulfill debt obligations. The company has ongoing legal proceedings related to a terminated joint venture and has not yet made cash payments under its settlement agreement with Auctus Fund LLC. The need for substantial capital to establish manufacturing facilities and execute strategic initiatives introduces execution risk. Market acceptance of NexBoard™ and related products depends on successful certification, competitive pricing, and effective distribution partnerships. Delays or failures in these areas could limit commercialization and revenue generation.
Xeriant's moat is centered on its proprietary Durazite™ fire-retardant technology and its application in eco-friendly composite construction materials such as NexBoard™ and NexPatch™. The combination of patented nanotechnology, broad resistance properties, and potential to replace multiple traditional building materials provides a differentiated product offering. The Factor X Research Group adds a strategic innovation capability across multiple high-growth technology domains, potentially creating cross-sector synergies. However, the company's moat is contingent on successful commercialization, strategic partnerships, and capital availability to scale production and market penetration.
• Financial Risk: The company has low liquidity with a current ratio of 0.01 and reported net losses, indicating potential challenges in meeting short-term obligations and funding operations.
• Execution Risk: Scaling production of NexBoard™ and securing strategic partnerships and financing are critical and may be hindered by capital constraints or market conditions.
• Legal Risk: Ongoing litigation related to the terminated joint venture with XTI Aircraft may result in financial or operational impacts.
• Market Acceptance Risk: The success of NexBoard™ depends on market adoption, competitive positioning, and the ability to replace established construction materials.
Business trends: Focus on commercialization of eco-friendly advanced materials with proprietary fire-retardant technology and expansion of Factor X innovation engine across multiple high-tech domains.
Execution milestones: Completion of extensive certification testing for NexBoard™, initiation of licensing agreements, scaling production via contract manufacturers, and restructuring of debt obligations with Auctus Fund LLC.
Key risks: Financial constraints impacting liquidity and capital availability, execution risks in scaling production and market adoption, ongoing legal proceedings related to terminated joint venture, and dependency on strategic partnerships for distribution and financing.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- Xeriant, Inc. is focused on discovery, development, and commercialization of transformative technologies, primarily advanced materials for multiple industrial sectors [S1].
- The company markets advanced materials under the DUREVER™ brand, including NexBoard™, an eco-friendly composite construction panel made from recycled plastic and fiber waste, and NexPatch™, a fire-resistant joint compound [S1].
- Both NexBoard™ and NexPatch™ incorporate proprietary fire-retardant technology called Durazite™ [S1].
- NexBoard™ exhibits resistance to fire, water, mold, insects, cracking, abrasion, compression, and puncture, designed to replace traditional construction materials such as drywall, plywood, OSB, MDF, MgO board, and cement board [S1].
- Durazite™ technology has potential applications beyond construction materials, in various industries seeking enhanced product performance [S1].
- The company seeks strategic partners in building materials and other industries to leverage distribution networks and markets [S1].
- Xeriant has been developing advanced materials including nanotechnology since 2023, with production process testing for NexBoard™ starting in 2025 [S1].
- The company collaborates with manufacturers in other industries to incorporate its technology, with licensing agreements anticipated to generate revenue starting in Q4 2026 [S1].
- Certification testing for NexBoard™ began in June 2026, with successful completion of 16 tests covering fire, thermal, impact, mechanical, surface, indoor air quality, moisture, mold, and chemical resistance [S1].
- NexBoard™ is positioned for both interior and exterior wallboard applications and will be available in standard panel sizes and thicknesses [S1].
- Xeriant established Factor X Research Group in November 2025 as an innovation engine targeting aerospace, defense, advanced materials, AI, quantum computing, and other domains [S1].
- Factor X is led by Brigadier General (Ret.) Blaine D. Holt, appointed President, focusing on technology evaluation and commercialization to accelerate shareholder value [S1].
- The company has a history of a joint venture with XTI Aircraft for eVTOL aircraft design, which was terminated in 2023, followed by legal proceedings against XTI [S1].
- Xeriant issued a Senior Secured Promissory Note to Auctus Fund LLC for bridge loan funding related to the XTI merger, with multiple amendments and restructuring agreements through 2025 and 2026 [S1].
- The company entered a Settlement Agreement with Auctus in October 2025 to restructure debt, including issuance of common stock and scheduled payments, with extensions granted through October 2026 [S1].
- As of September 30, 2026, Xeriant reported current assets of $39,255 and current liabilities of $4,988,527, resulting in a current ratio of 0.01 and a cash ratio of 0.34 [S2].
- Net income for the quarter ending September 30, 2026, was a loss of $499,542 with basic and diluted EPS of $0.00 [S2].
- The company had cash and equivalents of $1,693,495 as of March 31, 2022, per the latest available SEC snapshot [S2].
- Xeriant is working with contract manufacturers to scale production of NexBoard™ and is in discussions with potential strategic partners and investment banks for financing manufacturing facilities, including green bond issuances [S1].
- The company has not made cash payments related to the Auctus settlement agreement as of June 30, 2026, but is actively working to secure funding to fulfill obligations [S1].
- Recent news coverage includes no direct business updates on Xeriant but reflects broader market and sector conditions [N1][N2].
Generated 2026-11-16
- S1 | 2026-09-28 | 10-K
- S2 | 2026-11-16 | 10-Q
- N1 | 2026-11-16 | www.nasdaq.com | Rising Indian Sugar Production Weighs on Prices | https://www.nasdaq.com/articles/rising-indian-sugar-production-weighs-prices
- N2 | 2026-11-16 | www.nasdaq.com | Sugar Prices Slide as India Ramps Up Sugar Production | https://www.nasdaq.com/articles/sugar-prices-slide-india-ramps-sugar-production
- N3 | 2026-11-16 | www.nasdaq.com | CapsoVision Narrows Q3 Loss To $7.3 Mln; To Apply For CapsoCam Colon FDA Clearance By 2026 End | https://www.nasdaq.com/articles/capsovision-narrows-q3-loss-73-mln-apply-capsocam-colon-fda-clearance-2026-end
- N4 | 2026-11-16 | www.nasdaq.com | Walmart Inc. Appoints Joseph E. Creed to Board of Directors | https://www.nasdaq.com/articles/walmart-inc-appoints-joseph-e-creed-board-directors
- N5 | 2026-11-16 | www.nasdaq.com | Ballard Power Systems Inc. Acquires GeoPura Limited and Reports Third Quarter 2026 Results | https://www.nasdaq.com/articles/ballard-power-systems-inc-acquires-geopura-limited-and-reports-third-quarter-2026-results
- N6 | 2026-11-16 | www.nasdaq.com | Galectin Therapeutics Inc. Reports September 30, 2026 Financial Results and $105.8 million Debt Conversion | https://www.nasdaq.com/articles/galectin-therapeutics-inc-reports-september-30-2026-financial-results-and-1058-million
- N7 | 2026-09-28 | www.nasdaq.com | Stocks Settle Lower on Rising Bond Yields | https://www.nasdaq.com/articles/stocks-settle-lower-rising-bond-yields-0
- N8 | 2026-09-28 | www.nasdaq.com | Nat-Gas Prices Fall as Force Majeure Lifted on Appalachian Pipeline | https://www.nasdaq.com/articles/nat-gas-prices-fall-force-majeure-lifted-appalachian-pipeline
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


